Delivery included to the United States

Gynecological Cancers

Gynecological Cancers Genetic and Epignetic Targets and Drug Development - Current Clinical Oncology

1st ed. 2016

Hardback (26 Jul 2016)

  • $136.46
Add to basket

Includes delivery to the United States

10+ copies available online - Usually dispatched within 7 days

Publisher's Synopsis

Facilitating the collaboration between the basic, translational, and clinical sciences, this book provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers. Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development gathers all of the molecular and cellular aspects of gynecological cancer together within one volume, providing detailed and up-to-date information on the etiology, diagnosis, and treatment of gynecological cancers. 


Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development ​also discusses the racial and ethnic disparities in the treatment of gynecological cancers through cost effective modalities like single visit screening and diagnosis, well women clinics, and mobile clinics. Written and edited by leaders in the field, this volume within the Current Clinical Oncology series is an indispensable resource for today's practicing oncologist.

Book information

ISBN: 9783319329055
Publisher: Springer International Publishing
Imprint: Springer
Pub date:
Edition: 1st ed. 2016
DEWEY: 616.99465
DEWEY edition: 23
Language: English
Number of pages: 173
Weight: 5474g
Height: 254mm
Width: 178mm
Spine width: 16mm